{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Méticilline : Questions médicales les plus fréquentes",
"headline": "Méticilline : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Méticilline : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-11",
"dateModified": "2025-04-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Méticilline"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pénicillines",
"url": "https://questionsmedicales.fr/mesh/D010406",
"about": {
"@type": "MedicalCondition",
"name": "Pénicillines",
"code": {
"@type": "MedicalCode",
"code": "D010406",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.633.100.300.750"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Méticilline",
"alternateName": "Methicillin",
"code": {
"@type": "MedicalCode",
"code": "D008712",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Carmen Torres",
"url": "https://questionsmedicales.fr/author/Carmen%20Torres",
"affiliation": {
"@type": "Organization",
"name": "Area de Bioquímica y Biología Molecular, Universidad de La Rioja, Logroño, Spain."
}
},
{
"@type": "Person",
"name": "Eric S Donkor",
"url": "https://questionsmedicales.fr/author/Eric%20S%20Donkor",
"affiliation": {
"@type": "Organization",
"name": "1 Department of Medical Microbiology, University of Ghana, Accra, Ghana."
}
},
{
"@type": "Person",
"name": "Patrick Butaye",
"url": "https://questionsmedicales.fr/author/Patrick%20Butaye",
"affiliation": {
"@type": "Organization",
"name": "School of Veterinary Medicine, Ross University, West Farm 000265, Saint Kitts and Nevis."
}
},
{
"@type": "Person",
"name": "Assia Mairi",
"url": "https://questionsmedicales.fr/author/Assia%20Mairi",
"affiliation": {
"@type": "Organization",
"name": "Laboratoire d'Ecologie Microbienne, FSNV, Université de Bejaia, Bejaia 06000, Algeria."
}
},
{
"@type": "Person",
"name": "Abdelaziz Touati",
"url": "https://questionsmedicales.fr/author/Abdelaziz%20Touati",
"affiliation": {
"@type": "Organization",
"name": "Laboratoire d'Ecologie Microbienne, FSNV, Université de Bejaia, Bejaia 06000, Algeria."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "C-Reactive Protein as a Prognostic Biomarker for Gynecologic Cancers: A Meta-Analysis.",
"datePublished": "2022-10-11",
"url": "https://questionsmedicales.fr/article/36268143",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/6833078"
}
},
{
"@type": "ScholarlyArticle",
"name": "Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/35997934",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s12013-022-01089-x"
}
},
{
"@type": "ScholarlyArticle",
"name": "A rapid fluorescent aptasensor for point-of-care detection of C-reactive protein.",
"datePublished": "2022-06-04",
"url": "https://questionsmedicales.fr/article/35714415",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.talanta.2022.123661"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis.",
"datePublished": "2022-07-09",
"url": "https://questionsmedicales.fr/article/35821191",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejim.2022.07.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study.",
"datePublished": "2022-06-24",
"url": "https://questionsmedicales.fr/article/35766701",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1806-9282.20220236"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétérocycliques à cycles fusionnés",
"item": "https://questionsmedicales.fr/mesh/D000072471"
},
{
"@type": "ListItem",
"position": 4,
"name": "Composés hétérobicycliques",
"item": "https://questionsmedicales.fr/mesh/D006574"
},
{
"@type": "ListItem",
"position": 5,
"name": "bêta-Lactames",
"item": "https://questionsmedicales.fr/mesh/D047090"
},
{
"@type": "ListItem",
"position": 6,
"name": "Pénicillines",
"item": "https://questionsmedicales.fr/mesh/D010406"
},
{
"@type": "ListItem",
"position": 7,
"name": "Méticilline",
"item": "https://questionsmedicales.fr/mesh/D008712"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Méticilline - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Méticilline",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Méticilline",
"description": "Comment diagnostiquer une infection résistante à la méticilline ?\nQuels tests sont utilisés pour détecter la résistance à la méticilline ?\nQuels symptômes indiquent une infection à staphylocoque ?\nQuand faut-il suspecter une infection à SARM ?\nQuel rôle joue la culture de sang dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=C-Reactive+Protein&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Méticilline",
"description": "Quels sont les symptômes d'une infection à SARM ?\nComment se manifeste une infection cutanée ?\nQuels signes indiquent une infection systémique ?\nLes infections à méticilline provoquent-elles des douleurs ?\nQuels symptômes nécessitent une consultation urgente ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=C-Reactive+Protein&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Méticilline",
"description": "Comment prévenir les infections à SARM ?\nLes antibiotiques préventifs sont-ils efficaces ?\nQuel rôle joue la vaccination dans la prévention ?\nComment éviter la propagation en milieu hospitalier ?\nLes soins des plaies aident-ils à prévenir les infections ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=C-Reactive+Protein&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Méticilline",
"description": "Quel est le traitement principal des infections à SARM ?\nComment traiter une infection cutanée causée par SARM ?\nLes antibiotiques oraux sont-ils efficaces contre SARM ?\nQuelle est l'importance de l'antibiogramme ?\nPeut-on utiliser la méticilline pour traiter le SARM ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=C-Reactive+Protein&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Méticilline",
"description": "Quelles sont les complications possibles d'une infection à SARM ?\nComment une infection à SARM peut-elle affecter le cœur ?\nLes infections à SARM peuvent-elles causer des lésions pulmonaires ?\nQuels risques pour les patients diabétiques ?\nLes infections à SARM peuvent-elles être fatales ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=C-Reactive+Protein&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Méticilline",
"description": "Quels sont les principaux facteurs de risque pour SARM ?\nLe partage d'objets personnels augmente-t-il le risque ?\nLes athlètes sont-ils plus à risque d'infection à SARM ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes patients en soins intensifs sont-ils à risque ?",
"url": "https://questionsmedicales.fr/mesh/D008712?mesh_terms=C-Reactive+Protein&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection résistante à la méticilline ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des cultures bactériennes et des tests de sensibilité aux antibiotiques sont effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter la résistance à la méticilline ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le test de diffusion sur gélose et le test d'agar de dilution sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection à staphylocoque ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, rougeur, gonflement et douleur au site d'infection sont des signes courants."
}
},
{
"@type": "Question",
"name": "Quand faut-il suspecter une infection à SARM ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "En cas d'infections cutanées récurrentes ou de non-réponse aux antibiotiques classiques."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la culture de sang dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'identifier la présence de bactéries dans le sang et leur sensibilité."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une infection à SARM ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des rougeurs, des douleurs, des abcès et parfois de la fièvre."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une infection cutanée ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par des rougeurs, des gonflements, de la chaleur et des douleurs."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection systémique ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre élevée, frissons, fatigue extrême et confusion peuvent indiquer une infection grave."
}
},
{
"@type": "Question",
"name": "Les infections à méticilline provoquent-elles des douleurs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections peuvent causer des douleurs localisées ou généralisées selon la gravité."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une consultation urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme une fièvre élevée, des difficultés respiratoires ou des éruptions cutanées graves."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections à SARM ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiquer une bonne hygiène, se laver les mains et éviter le partage d'objets personnels."
}
},
{
"@type": "Question",
"name": "Les antibiotiques préventifs sont-ils efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation d'antibiotiques préventifs n'est généralement pas recommandée sans indication."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la vaccination dans la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin spécifique contre le SARM, mais la vaccination générale aide."
}
},
{
"@type": "Question",
"name": "Comment éviter la propagation en milieu hospitalier ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des protocoles stricts d'hygiène et d'isolement des patients infectés sont essentiels."
}
},
{
"@type": "Question",
"name": "Les soins des plaies aident-ils à prévenir les infections ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un bon soin des plaies réduit le risque d'infection par des bactéries résistantes."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal des infections à SARM ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections à SARM sont généralement traitées avec des antibiotiques comme la vancomycine."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection cutanée causée par SARM ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement peut inclure des antibiotiques et parfois un drainage chirurgical des abcès."
}
},
{
"@type": "Question",
"name": "Les antibiotiques oraux sont-ils efficaces contre SARM ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains antibiotiques oraux comme la clindamycine peuvent être efficaces selon la sensibilité."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'antibiogramme ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'antibiogramme détermine la sensibilité des bactéries aux antibiotiques, guidant le traitement."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la méticilline pour traiter le SARM ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le SARM est résistant à la méticilline et nécessite d'autres antibiotiques."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles d'une infection à SARM ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections profondes, des septicémies et des infections osseuses."
}
},
{
"@type": "Question",
"name": "Comment une infection à SARM peut-elle affecter le cœur ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut provoquer une endocardite, une infection des valves cardiaques, potentiellement mortelle."
}
},
{
"@type": "Question",
"name": "Les infections à SARM peuvent-elles causer des lésions pulmonaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des pneumonies, surtout chez les patients immunodéprimés."
}
},
{
"@type": "Question",
"name": "Quels risques pour les patients diabétiques ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients diabétiques sont plus susceptibles de développer des infections graves à SARM."
}
},
{
"@type": "Question",
"name": "Les infections à SARM peuvent-elles être fatales ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent être mortelles, surtout si elles ne sont pas traitées rapidement et correctement."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour SARM ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'hospitalisation, les interventions chirurgicales et l'immunodépression."
}
},
{
"@type": "Question",
"name": "Le partage d'objets personnels augmente-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le partage d'objets comme les serviettes ou les rasoirs peut favoriser la transmission."
}
},
{
"@type": "Question",
"name": "Les athlètes sont-ils plus à risque d'infection à SARM ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en raison des contacts physiques fréquents et des blessures cutanées potentielles."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles ont un système immunitaire affaibli, ce qui augmente le risque d'infections."
}
},
{
"@type": "Question",
"name": "Les patients en soins intensifs sont-ils à risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en raison de leur état de santé fragile et de l'exposition à des bactéries résistantes."
}
}
]
}
]
}
The prognostic role of CRP (C-reactive protein) in gynecological tumors has been previously reported in individual studies, but whether CRP can be used as a separate potential prognostic factor has no...
A systematic search was carried out to find the literature evaluating the predictive role of CRP in the prognosis of gynecological cancer patients. For the purpose of determining the relationship betw...
A total of 19 studies, including 4062 patients, were analyzed retrospectively. The FIGO stage was related to the CRP level (OR = 0.43, 95% CI: 0.19-1.00). Age, lymph node metastasis, and histological ...
CRP may be utilized as a prognostic indicator for a variety of gynecologic malignancies, including cervical cancer, ovarian cancer, endometrial cancer, and vulvar cancer....
The acute phase C-reactive protein (CRP) is mainly synthesized and secreted by the liver in a cytokine-mediated response to infection or inflammation and circulates as a pentamer (pCRP) in plasma. Rec...
In this paper, we report on a novel fluorescent aptasensor based on aptamers modified by both nitrogen-doped graphene quantum dots (N-GQDs) and gold nanoparticles (AuNPs) for the detection of C-reacti...
To evaluate the association between C-reactive protein (CRP) and 10-year risk of cardiovascular (CV) events using the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis (ERS-RA), b...
ERS-RA was calculated in 1,251 "Cardiovascular Obesity and Rheumatic Disease Study (CORDIS)" database patients [(age 60.4(9.3) years; 78% female; disease duration, 11.6(8) years; CDAI, 9(9); CRP, 6.8(...
The mean (SD) 10-year risk of CV events was 12.9% (10). After adjusting for the use of DMARDs and biologics, CRP concentrations were significantly associated with 10-year risk of CV events (coefficien...
In a large cohort of RA patients without previous cardiovascular events, a 20 mg/L increase in CRP concentrations was associated with a 1% increase in 10-year risk of CV events. This suggests that act...
Chronic hepatitis C (CHC) is one of the most important health problems affecting the significant rate of world population and it may lead to cirrhosis and hepatocellular carcinoma. C-reactive protein ...
Patients with CHC infection who visited outpatient and inpatient internal medicine clinics of our institution between January 2021 and December 2021 were enrolled to this retrospective study. CLR of t...
Median CLR of CHC and control subjects was 2.61 (5.13%) and 0.31 (0.37%), respectively. CLR of the CHC group was significantly increased compared to the CLR of the controls (p<0.001). There was a sign...
Increased CLR in patients with CHC may be an alarming finding of liver fibrosis, as CLR is associated with both CHC and hepatic fibrosis....
Life's Essential 8 (LE8) is a score that includes modifiable risk factors for cardiovascular disease. Four health behaviors (diet, physical activity, nicotine exposure and sleep health) and four healt...
We investigate the interactions between C-reactive protein (CRP) and new CRP-binding peptide materials using experimental (biological and physicochemical) methods with the support of theoretical simul...
To assess whether low-grade inflammation, measured by serum high-sensitivity C-reactive protein (hsCRP) levels, is associated with...
A retrospective study....
University-affiliated IVF center....
In the present study, 875 women of normal weight who underwent their first fresh embryo transfer (ET) cycles for IVF treatment were divided into three groups according to serum concentrations of hsCRP...
Serum from women undergoing IVF was collected on days 2-4 of a spontaneous menstrual cycle prior to the commencement of ovarian stimulation....
The IVF outcomes included implantation, biochemical pregnancy, clinical pregnancy, miscarriage and live birth rates....
The women were divided into three groups according to the baseline serum levels of hsCRP as follows: low hsCRP (<1 mg/L; n=517), medium hsCRP (1-3 mg/L; n= 270), high hsCRP (>3 mg/L; n=88). The matern...
Among women of normal weight undergoing their first IVF treatment, it was found that low-grade inflammation was associated with reduced clinical pregnancy and live birth rates following fresh ET cycle...
Interest in using bedside C-reactive protein (CRP) and ferritin levels to identify patients with hyperinflammatory sepsis who might benefit from anti-inflammatory therapies has piqued with the COVID-1...
A prospective, observational cohort study....
Children with sepsis and organ failure in nine pediatric intensive care units in the United States....
Two hundred and fifty-five children were enrolled. Five distinct clinical multi-trajectory groups were identified. Plasma CRP (mg/dL), ferritin (ng/mL), and 31 cytokine levels were measured at two tim...
Group 1 had normal CRP and ferritin levels ( n = 8; 0% mortality); Group 2 had high CRP levels that became normal, with normal ferritin levels throughout ( n = 80; 5% mortality); Group 3 had high ferr...
Bedside CRP and ferritin levels can be used together to distinguish groups of children with sepsis who have different systemic inflammation cytokine responses and mortality risks. These data suggest f...
Social relationships are an important driver of health, and inflammation has been proposed as a key neurobiological mechanism to explain this effect. Behavioral researchers have focused on social rela...